Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of XomeXBio is 1.2% (low). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
5 mandates
4
active directors
JPP CONSULTING SRLDirectorTONGLET CONSULT SRLManaging directorHui YangDirector+2 in history
All directors & mandates Publicationslatest 22-12-2025
11
publications in the State GazetteCapital increase of €680,000All publications & acts Network & structure
12
connected companiesSee network & structure
Connections
12 connected companiesParent · 2 subsidiaries · 1 location
Control→
Trust signals
3 signalsMore than 3 years active
Founded in 2023 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.2%
Low
0%0,5%1,5%4%10%≥25%
Young company
+Lower-failure-rate sector
−Higher-failure-rate region
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Speur- en ontwikkelingswerk op biotechnologisch gebied72110
Primary activity highlighted.
Names & trade names
| Legal nameFR | XomeXBio |
Registered office
Rue Clément Ader 10
6041 Charleroi, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.